Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srinivas Nalamachu

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Journal of Opioid Management|December 19, 2012
Safety and tolerability of OROS® hydromorphone ER in adults with chronic noncancer and cancer pain: pooled analysis of 13 studiesMartin E Hale, Mark S Wallace, Donald R Taylor, et al.
Expert Opinion on Drug Safety|June 7, 2014
Drug-drug interaction between NSAIDS and low-dose aspirin: a focus on cardiovascular and GI toxicitySrinivas Nalamachu, Joseph V Pergolizzi, Robert B Raffa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2021
Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced ConstipationJan Tack, Michael Camilleri, Martin Hale, et al.
Pain Practice : the Official Journal of World Institute of Pain|June 22, 2012
A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back painJoseph V Pergolizzi, Robert B Raffa, Robert Taylor, et al.
Pain and Therapy|April 8, 2025
Multimodal Therapies for the Treatment of Neuropathic Pain: The Role of Lidocaine Patches in Combination Therapy: A Narrative ReviewSrinivas Nalamachu, Theresa Mallick-Searle, Jeremy Adler, et al.
Pain Medicine (Malden, Mass.)|August 25, 2015
An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release HydrocodoneSrinivas Nalamachu, Oscar A deLeon-Casasola, Cynthia Y Robinson, et al.
Drug Delivery and Translational Research|August 27, 2016
Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergenciesRobert B Raffa, Robert Taylor, Joseph V Pergolizzi, et al.
Postgraduate Medicine|August 3, 2010
Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: a pooled analysisArnold J Weil, Gary E Ruoff, Srinivas Nalamachu, et al.
Journal of Pain Research|December 5, 2014
A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic painSrinivas Nalamachu, Richard L Rauck, Martin E Hale, et al.
Current Medical Research and Opinion|July 7, 2017
Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a single ascending dose study in opioid-naïve healthy volunteersRichard Rauck, D Alexander Oh, Neha Parikh, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of Opioid Management|December 19, 2012
Safety and tolerability of OROS® hydromorphone ER in adults with chronic noncancer and cancer pain: pooled analysis of 13 studiesMartin E Hale, Mark S Wallace, Donald R Taylor, et al.
Expert Opinion on Drug Safety|June 7, 2014
Drug-drug interaction between NSAIDS and low-dose aspirin: a focus on cardiovascular and GI toxicitySrinivas Nalamachu, Joseph V Pergolizzi, Robert B Raffa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2021
Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced ConstipationJan Tack, Michael Camilleri, Martin Hale, et al.
Pain Practice : the Official Journal of World Institute of Pain|June 22, 2012
A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back painJoseph V Pergolizzi, Robert B Raffa, Robert Taylor, et al.
Pain and Therapy|April 8, 2025
Multimodal Therapies for the Treatment of Neuropathic Pain: The Role of Lidocaine Patches in Combination Therapy: A Narrative ReviewSrinivas Nalamachu, Theresa Mallick-Searle, Jeremy Adler, et al.
Pain Medicine (Malden, Mass.)|August 25, 2015
An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release HydrocodoneSrinivas Nalamachu, Oscar A deLeon-Casasola, Cynthia Y Robinson, et al.
Drug Delivery and Translational Research|August 27, 2016
Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergenciesRobert B Raffa, Robert Taylor, Joseph V Pergolizzi, et al.
Postgraduate Medicine|August 3, 2010
Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: a pooled analysisArnold J Weil, Gary E Ruoff, Srinivas Nalamachu, et al.
Journal of Pain Research|December 5, 2014
A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic painSrinivas Nalamachu, Richard L Rauck, Martin E Hale, et al.
Current Medical Research and Opinion|July 7, 2017
Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a single ascending dose study in opioid-naïve healthy volunteersRichard Rauck, D Alexander Oh, Neha Parikh, et al.
Pageof 6